Where Reporter = 'L' in the Appendix A, Reportable Diseases, Condition, and Related Event Table, cases of diseases shall be reported with the information required in Regulation 1 by the laboratory, or by an outpatient clinic that performs laboratory testing on site, whether or not associated with a hospital. The following laboratories shall also report:
1) out-of-state laboratories that maintain an office or collection facility in Colorado or arrange for collection of specimens in Colorado; and2) in-state laboratories that send specimens to out-of-state referral laboratories. The case shall be reported by a laboratory when a result diagnostic of or highly correlated with clinical illness is found. Laboratory assays which demonstrate only immunity should not be reported (for example, a single elevated rubella antibody titer obtained during routine prenatal screening should not be reported). For organisms so noted in Appendix A, Reportable Diseases, Condition, and Related Event Table, testing laboratories shall routinely submit bacterial culture isolates or patient clinical material that yields positive findings to the Department, Laboratory Services Division. Clinical material is defined as:
(i) A culture isolate containing the infectious organism for which submission of material is required, or(ii) If an isolate is not available, material containing the infectious organism for which submission of material is required, in the following order of preference: (C) other laboratory material. All specimens shall be accompanied by the following information:
(a) Patient's name, date of birth, sex, race, ethnicity, phone number, physical address (including city and county), email address, and preferred language(b) Name and address of responsible physician or other health care provide(c) Name of disease or condition(d) Laboratory information - test name, collection date and specimen type. Laboratories should make an effort to report all test results electronically, whenever possible.6 CCR 1009-1, reg. Regulation 3
37 CR 18, September 25, 2014, effective 10/15/201438 CR 20, October 25, 2015, effective 11/14/201540 CR 08, April 25, 2017, effective 5/15/201741 CR 12, June 25, 2018, effective 7/15/201842 CR 10, May 25, 2019, effective 7/1/201944 CR 18, September 25, 2021, effective 10/15/202146 CR 06, March 25, 2023, effective 2/15/202346 CR 10, May 25, 2023, effective 6/14/2023